ARCHIVES

EORTC Screening, Pharmacology Group Focuses On CNU

This article is from The Cancer Letter archive.

Vol. 13 No. 01 | January 2, 1987

Download PDF Visit The Full Archive

Related Articles

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994

ESAs Increase Risk of Death by 11 Percent, Blood Clots by 59 Percent, Meta-Analysis Finds; Study To Be Updated At ASCO.

June 1, 2007

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

NIH Authorization Bills Require NCI To Spend 10% On Cancer control

February 12, 1993

July issue of Business & Regulatory report (8 additional pages) included.

July 30, 2004

Peter Boyle Elected IARC Director

May 23, 2003